Cellectis S.A. (EPA:ALCLS)
France · Delayed Price · Currency is EUR 1.254
-0.036 (-2.79%)
Oct 2, 2026, 5:35 PM CET
Cellectis Employees
As of December 31, 2025, Cellectis had 229 total employees, including 224 full-time and 5 part-time employees. The number of employees increased by 7 or 3.15% compared to the previous year.
Employees
229
Change (1Y)
7
Growth (1Y)
3.15%
Revenue / Employee
€246,098
Profits / Employee
€251,847
Market Cap
91.16M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 229 | 7 | 3.15% | 224 | 5 |
| Dec 31, 2024 | 222 | 1 | 0.45% | 216 | 6 |
| Dec 31, 2023 | 221 | -16 | -6.75% | 216 | 5 |
| Dec 31, 2022 | 237 | -63 | -21.00% | 231 | 6 |
| Dec 31, 2021 | 300 | 19 | 6.76% | 294 | 6 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| Transgene | 145 |
| Adocia | 73 |
| Sensorion | 66 |
| OSE Immunotherapeutics | 64 |
| Fermentalg | 64 |
| ABIONYX Pharma | 49 |
| Valerio Therapeutics Société anonyme | 25 |
Cellectis News
- 1 day ago - Cellectis Unveils In Vivo Gene-Editing Plans for Severe Lipid Disorders - MarketBeat
- 1 day ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS - PRNewsWire
- 2 days ago - Cellectis Transcript: Stifel 2026 Virtual Cardiometabolic Forum - Transcripts
- 3 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS - GlobeNewsWire
- 8 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS - PRNewsWire
- 10 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS - GlobeNewsWire
- 13 days ago - CLLS Investors Have Opportunity to Join Cellectis S.A. Fraud Investigation with SBS Law - Business Wire
- 15 days ago - CLLS INVESTOR ALERT: Investigation of Cellectis S.A. Announced by Holzer & Holzer, LLC - GlobeNewsWire